State of Tennessee Treasury Department grew its position in shares of HCA Healthcare Inc (NYSE:HCA) by 15.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 271,586 shares of the company’s stock after acquiring an additional 35,580 shares during the quarter. State of Tennessee Treasury Department’s holdings in HCA Healthcare were worth $40,143,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Pendal Group Ltd raised its stake in shares of HCA Healthcare by 21.7% during the fourth quarter. Pendal Group Ltd now owns 28,476 shares of the company’s stock valued at $4,209,000 after purchasing an additional 5,077 shares in the last quarter. Pinnacle Financial Partners Inc. raised its stake in shares of HCA Healthcare by 8.8% during the fourth quarter. Pinnacle Financial Partners Inc. now owns 109,250 shares of the company’s stock valued at $16,148,000 after purchasing an additional 8,817 shares in the last quarter. Candriam Luxembourg S.C.A. raised its stake in shares of HCA Healthcare by 10.8% during the fourth quarter. Candriam Luxembourg S.C.A. now owns 110,009 shares of the company’s stock valued at $16,260,000 after purchasing an additional 10,700 shares in the last quarter. American International Group Inc. raised its position in HCA Healthcare by 0.8% in the fourth quarter. American International Group Inc. now owns 113,266 shares of the company’s stock worth $16,742,000 after acquiring an additional 883 shares in the last quarter. Finally, Cedar Capital LLC raised its position in HCA Healthcare by 24.6% in the fourth quarter. Cedar Capital LLC now owns 3,626 shares of the company’s stock worth $536,000 after acquiring an additional 715 shares in the last quarter. 69.54% of the stock is owned by institutional investors.

Several brokerages have commented on HCA. Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $170.00 to $173.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 29th. Credit Suisse Group boosted their price objective on HCA Healthcare from $169.00 to $173.00 and gave the stock an “outperform” rating in a report on Wednesday, January 29th. Citigroup boosted their price objective on HCA Healthcare from $156.00 to $168.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Stephens boosted their price objective on HCA Healthcare from $175.00 to $180.00 and gave the stock an “overweight” rating in a report on Wednesday, January 29th. Finally, Deutsche Bank initiated coverage on HCA Healthcare in a report on Friday, January 3rd. They set a “buy” rating and a $140.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $163.81.

In related news, insider Michael S. Cuffe sold 5,891 shares of the business’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $147.04, for a total value of $866,212.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Jane D. Englebright sold 2,049 shares of the business’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $143.50, for a total value of $294,031.50. Following the completion of the sale, the senior vice president now directly owns 10,480 shares of the company’s stock, valued at approximately $1,503,880. The disclosure for this sale can be found here. In the last three months, insiders sold 68,727 shares of company stock valued at $10,018,829. 2.70% of the stock is currently owned by company insiders.

NYSE:HCA traded down $1.40 on Friday, hitting $149.48. 91,110 shares of the company’s stock traded hands, compared to its average volume of 1,515,313. HCA Healthcare Inc has a 1 year low of $110.31 and a 1 year high of $151.97. The firm has a 50-day moving average price of $146.75 and a 200-day moving average price of $134.29. The company has a market cap of $51.00 billion, a PE ratio of 14.85, a price-to-earnings-growth ratio of 1.18 and a beta of 0.93.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 28th. The company reported $3.09 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $3.09. HCA Healthcare had a negative return on equity of 242.04% and a net margin of 6.83%. The company had revenue of $13.52 billion for the quarter, compared to analysts’ expectations of $13.37 billion. During the same quarter in the previous year, the business posted $3.01 EPS. The business’s revenue for the quarter was up 10.2% on a year-over-year basis. Analysts predict that HCA Healthcare Inc will post 11.68 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Monday, March 2nd will be paid a $0.43 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.15%. HCA Healthcare’s payout ratio is presently 15.24%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: What is the Euro STOXX 50 Index?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.